Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? – A cost-effectiveness analysis
Phi, Xuan-Anh, Greuter, Marcel J.W., Obdeijn, Inge-Marie, Oosterwijk, Jan C., Feenstra, Talitha L., Houssami, Nehmat, de Bock, Geertruida H.Volume:
45
Language:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2019.03.004
Date:
June, 2019
File:
PDF, 492 KB
english, 2019